Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
BR-6002 by Boryung Pharmaceutical for Duodenal Ulcer: Likelihood of Approval
BR-6002 is under clinical development by Boryung Pharmaceutical and currently in Phase I for Duodenal Ulcer. According to GlobalData, Phase...
BR-6002 by Boryung Pharmaceutical for Cardiovascular Disease: Likelihood of Approval
BR-6002 is under clinical development by Boryung Pharmaceutical and currently in Phase I for Cardiovascular Disease. According to GlobalData, Phase...
BR-6002 by Boryung Pharmaceutical for Gastric Ulcers: Likelihood of Approval
BR-6002 is under clinical development by Boryung Pharmaceutical and currently in Phase I for Gastric Ulcers. According to GlobalData, Phase...